Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Herzig

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Transfusion|May 21, 1999
The transfusion needs of an autologous bone marrow transplant patient with IgA deficiencyC E Meena-Leist, D R Fleming, M Heye, et al.
Progress in Clinical and Biological Research|January 1, 1977
Granulocyte transfusion therapy for life-threatening bacteremia: results of transfusion trials at the National Cancer InstituteR G Graw, F G Stout, R H Herzig, et al.
Cancer|October 1, 1985
High-dose cytosine arabinoside in previously treated patients with poor-prognosis non-Hodgkin's lymphomaD J Adelstein, H M Lazarus, J D Hines, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1983
Long-term survival of patients with multiple myeloma and acute renal failure at presentationH M Lazarus, D J Adelstein, R H Herzig, et al.
American Journal of Ophthalmology|November 1, 1982
Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabineJ H Lass, H M Lazarus, M D Reed, et al.
Breast Cancer Research and Treatment|April 1, 1988
Autologous bone marrow transplantation in breast cancer. A panel discussionW L McGuire, R H Herzig, C F Lemaistre, et al.
Journal of Hematotherapy & Stem Cell Research|January 25, 2000
Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokinesL Qiu, R Meagher, S Welhausen, et al.
Journal of Hematotherapy & Stem Cell Research|February 15, 2001
Mobilization of peripheral blood stem cells in high-risk breast cancer patients using G-CSF after standard dose docetaxelD R Fleming, J Goldsmith, G H Goldsmith, et al.
Bone Marrow Transplantation|March 7, 1998
A detailed analysis of charges for hematopoietic stem cell transplantation at a children's hospitalR M Kline, S Meiman, M D Tarantino, et al.
Seminars in Oncology|June 1, 1985
Central nervous system toxicity with high-dose cytosine arabinosideR H Herzig, H M Lazarus, G P Herzig, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Transfusion|May 21, 1999
The transfusion needs of an autologous bone marrow transplant patient with IgA deficiencyC E Meena-Leist, D R Fleming, M Heye, et al.
Progress in Clinical and Biological Research|January 1, 1977
Granulocyte transfusion therapy for life-threatening bacteremia: results of transfusion trials at the National Cancer InstituteR G Graw, F G Stout, R H Herzig, et al.
Cancer|October 1, 1985
High-dose cytosine arabinoside in previously treated patients with poor-prognosis non-Hodgkin's lymphomaD J Adelstein, H M Lazarus, J D Hines, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1983
Long-term survival of patients with multiple myeloma and acute renal failure at presentationH M Lazarus, D J Adelstein, R H Herzig, et al.
American Journal of Ophthalmology|November 1, 1982
Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabineJ H Lass, H M Lazarus, M D Reed, et al.
Breast Cancer Research and Treatment|April 1, 1988
Autologous bone marrow transplantation in breast cancer. A panel discussionW L McGuire, R H Herzig, C F Lemaistre, et al.
Journal of Hematotherapy & Stem Cell Research|January 25, 2000
Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokinesL Qiu, R Meagher, S Welhausen, et al.
Journal of Hematotherapy & Stem Cell Research|February 15, 2001
Mobilization of peripheral blood stem cells in high-risk breast cancer patients using G-CSF after standard dose docetaxelD R Fleming, J Goldsmith, G H Goldsmith, et al.
Bone Marrow Transplantation|March 7, 1998
A detailed analysis of charges for hematopoietic stem cell transplantation at a children's hospitalR M Kline, S Meiman, M D Tarantino, et al.
Seminars in Oncology|June 1, 1985
Central nervous system toxicity with high-dose cytosine arabinosideR H Herzig, H M Lazarus, G P Herzig, et al.
Pageof 10